Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells
Open Access
- 1 April 1986
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 53 (4) , 561-566
- https://doi.org/10.1038/bjc.1986.88
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometryInvestigational New Drugs, 1985
- Membrane alterations associated with progressive adriamycin resistanceBiochemical Pharmacology, 1982
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- Calmodulin and the cell cycle: Involvement in regulation of cell-cycle progressionCell, 1982
- CIRCUMVENTION OF RESISTANCE TO DAUNORUBICIN BY N-ACETYLDAUNORUBICIN IN EHRLICH ASCITES TUMOR1980
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- MECHANISMS OF RESISTANCE TO DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS1978
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts.1976
- Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin.1972